Nov 14, 2024 07:01AM
Aug 15, 2024 06:33AM
Aug 14, 2024 07:00AM
May 9, 2024 07:07AM
May 9, 2024 07:00AM
Apr 30, 2024 11:59AM
Apr 27, 2024 09:47AM ROSEN, LEADING INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation – BLUE
Apr 18, 2024 05:46PM
Apr 15, 2024 06:09PM
Apr 5, 2024 06:38PM
Apr 2, 2024 05:45PM
Mar 29, 2024 06:33PM
Mar 27, 2024 09:00PM
Mar 26, 2024 07:39AM bluebird bio (BLUE) Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 Guidance
Mar 26, 2024 07:01AM
Mar 18, 2024 08:22AM
Mar 18, 2024 08:00AM
Jan 8, 2024 08:00AM
Dec 20, 2023 03:59AM
Dec 19, 2023 09:41PM
Dec 18, 2023 04:01PM bluebird bio (BLUE) Announces Proposed $150M Share Offering
Dec 18, 2023 04:01PM
Dec 8, 2023 01:01PM
Dec 8, 2023 12:05PM
Nov 7, 2023 07:03AM
Nov 7, 2023 07:00AM
Nov 2, 2023 09:37AM
Oct 30, 2023 08:00AM bluebird bio (BLUE) to Sell Priority Review Voucher, if Granted, for $103M
Oct 30, 2023 08:00AM
Oct 24, 2023 08:00AM
Aug 16, 2023 07:01AM
Aug 16, 2023 07:00AM
Aug 8, 2023 07:03AM
Aug 8, 2023 07:00AM
Jul 25, 2023 08:00AM bluebird bio to Host Second Quarter 2023 Financial Results Conference Call and Provide Commercial Update
Jun 21, 2023 07:04AM
Jun 21, 2023 07:00AM
May 9, 2023 07:10AM
May 9, 2023 07:00AM
Apr 27, 2023 04:05PM
Apr 24, 2023 07:31AM
Apr 24, 2023 07:30AM bluebird bio Submits Biologics License Application (BLA) to FDA for lovotibeglogene autotemcel (lovo-cel) for Patients with Sickle Cell Disease (SCD) 12 years and Older with a History of Vaso-Occlusiv
Mar 29, 2023 07:13AM
Mar 29, 2023 07:00AM
Jan 19, 2023 05:36AM
Jan 18, 2023 08:00PM
Jan 18, 2023 06:44AM
Jan 18, 2023 06:43AM
Jan 6, 2023 07:30AM bluebird bio (BLUE) Sells Second Priority Review Voucher for $95 Million
Jan 6, 2023 07:30AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All